HGH 191AA (15 IU) refers to a recombinant human growth hormone (somatropin) used in clinical and research settings to support growth hormone activity in the body. It is identical in structure to the 191-amino-acid sequence naturally produced by the pituitary gland.
This compound is studied for its role in supporting tissue regeneration, metabolic function, fat utilization, and recovery processes. Because it is a prescription hormone, its use should only be determined and supervised by a qualified healthcare professional.
Concise summary of clinical use context.
HGH therapy is not standardized for self-administration and must be individualized.
HGH 191AA (somatropin) binds to growth hormone receptors in tissues throughout the body, triggering downstream signaling pathways that regulate growth, metabolism, and cellular repair.
A key pathway involves stimulation of insulin-like growth factor 1 (IGF-1), primarily produced in the liver. IGF-1 mediates many of the anabolic and regenerative effects associated with growth hormone, including protein synthesis, lipolysis (fat breakdown), and tissue repair. HGH also influences glucose metabolism and cellular energy utilization.
Potential Benefits (clinical context):
Possible Side Effects: